InsidersTradesSigma
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
无可用的信号评分。
Discover the detailed record of transactions filed by Stephens Kristin, Directeur du Développement. Director active across 1 company, notably Syros Pharmaceuticals, Inc.. Cumulatively, 6 reports have been logged. Split: 0 buy · 1 sell. Regulator: SEC (Form 4). The full history is openly available.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
6 条申报中的 6 条
Stephens Kristin is Directeur du Développement at Syros Pharmaceuticals, Inc., where she holds the role of Chief Development Officer. She has 6 filings in total, and the 6 sampled filings cover the period from 2022-04-04 to 2024-11-20; the most frequent transaction nature shown is Levée d'options.